# ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy

> **NCT05354973** · — · UNKNOWN · sponsor: **Stiftung Swiss Tumor Institute** · enrollment: 11 (estimated)

## Conditions studied

- Patient Reported Outcome Measures
- CAR T-Cell Therapy

## Interventions

- **DEVICE:** Consilium CareTM

## Key facts

- **NCT ID:** NCT05354973
- **Lead sponsor:** Stiftung Swiss Tumor Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-21
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2024-04-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354973, "ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05354973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*